Highlight
This study identifies novel germline compound mutations in the MPL gene and truncating mutations in SH2B3/LNK in patients with triple negative thrombocytosis, providing new molecular explanations for otherwise unexplained high platelet counts. These findings inform precision diagnostics and potential targeted therapies.
